Drug Type Synthetic peptide |
Synonyms |
Target |
Action agonists |
Mechanism APOE agonists(Apolipoprotein E agonists) |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Liver Cancer | Preclinical | Japan | 02 Jan 1999 | |
Hypercholesterolemia | Preclinical | Japan | - |